Execs On The Move: New Chiefs At Neurotech, Photocure

04 Dec 2018
Chart/Table

Executive Summary

An early investor in the Australian neurostimulation and neuro-diagnostic company Neurotech International is now the firm's CEO. And Photocure, focused on photodynamic technology for bladder cancer, hired a new chief executive from Ablynx.

Already Registered? Sign in to continue reading.

New to Medtech Insight? Start a free trial today!

Table
View full table

Topics

Subjects
Appointments
Commercial
Industries
Medical Device
Device Areas
In Vitro Diagnostics

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

Appointments Commercial Medical Device

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

MT124326

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

MT124326

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

Execs On The Move: New Chiefs At Neurotech, Photocure

Chart/Table

Executive Summary

Topics

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert